PT Medikaloka Hermina Tbk (HEAL.JK)
IDR 1420.0
(-1.73%)
IDR 1420.0
(-1.73%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1319.65 Billion | 503.58 Billion | 1856.33 Billion | 1126.48 Billion | 572.58 Billion | 241.67 Billion |
| Net Income | 437.34 Billion | 378.77 Billion | 995.97 Billion | 473.22 Billion | 255.36 Billion | 124.37 Billion |
| Depreciation & Amortization | 734.47 Billion | 124.8 Billion | 435.26 Billion | 294.92 Billion | 226.85 Billion | 203.32 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 147.83 Billion | -503.58 Billion | 425.1 Billion | 358.34 Billion | 90.35 Billion | -124.37 Billion |
| Investing Cash Flow | -1677.86 Billion | -1220.7 Billion | -1181.47 Billion | -1036.17 Billion | -605.66 Billion | -880.94 Billion |
| Investments in PPE | -1680.36 Billion | -1129.01 Billion | -1213.54 Billion | -889.65 Billion | -575.94 Billion | -764.16 Billion |
| Acquisitions | 2.49 Billion | 1.3 Billion | 560 Million | 893 Million | 2.05 Billion | 1.27 Billion |
| Investment purchases | - | -115 Million | -121.39 Billion | -121.15 Billion | -12.56 Billion | -113.49 Billion |
| Sales/Maturities of investments | - | -1.18 Billion | 120.83 Billion | -893 Million | -2.05 Billion | - |
| Other Investing Activities | -89 Billion | -91.69 Billion | 32.06 Billion | -25.37 Billion | -17.15 Billion | -3.29 Billion |
| Financing Cash Flow | 438.47 Billion | -158.6 Billion | -252.91 Billion | 181.01 Billion | 322.54 Billion | 620.65 Billion |
| Debt repayment | -521.79 Billion | -379.09 Billion | -99.46 Billion | -538.53 Billion | -530.88 Billion | -910.42 Billion |
| Dividends payments | -101.44 Billion | -86.66 Billion | -73.51 Billion | -35.56 Billion | -32.7 Billion | - |
| Common Stock Repurchased | -4.07 Billion | -163.38 Billion | -228.93 Billion | -60.59 Billion | - | - |
| Common Stock Issuance | 49.01 Billion | 67.43 Billion | - | 20 Billion | - | 1300.1 Billion |
| Other Financing Activities | -26.81 Billion | 403.1 Billion | -49.92 Billion | 795.71 Billion | 886.12 Billion | 230.96 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 774.94 Billion | 1286.51 Billion | 864.57 Billion | 593.25 Billion | 303.8 Billion | 322.42 Billion |
| Cash at end of period | 855.21 Billion | 774.94 Billion | 1286.51 Billion | 864.57 Billion | 593.25 Billion | 303.8 Billion |
| Capital Expenditure | -1680.36 Billion | -1129.01 Billion | -1213.54 Billion | -889.65 Billion | -575.94 Billion | -764.16 Billion |
| Effect of forex changes on cash | - | 364.15 Billion | - | - | - | - |
| Net cash flow / Change in cash | 80.26 Billion | -511.57 Billion | 421.94 Billion | 271.32 Billion | 289.45 Billion | -18.62 Billion |
| Free Cash Flow | -360.7 Billion | -625.42 Billion | 642.79 Billion | 236.83 Billion | -3.36 Billion | -522.49 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 125 Billion | 152.21 Billion | 190.94 Billion | 88.5 Billion | 437.34 Billion | 146.49 Billion |
| Depreciation & Amortization | 209.19 Billion | 202.54 Billion | 151.98 Billion | 229.18 Billion | 734.47 Billion | 185.62 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 7.37 Billion | 254.56 Billion | 289.89 Billion | 119.65 Billion | 147.83 Billion | 78.58 Billion |
| Investing Cash Flow | -711.16 Billion | -582.45 Billion | -535.82 Billion | -545.01 Billion | -1677.86 Billion | -492.03 Billion |
| Investments in PPE | -679.08 Billion | -582.52 Billion | -536.11 Billion | -546.01 Billion | -1680.36 Billion | -480.19 Billion |
| Acquisitions | 635 Million | 78 Million | 285 Million | 1 Billion | 2.49 Billion | 626 Million |
| Investment purchases | - | - | - | - | - | 2 Million |
| Sales/Maturities of investments | - | - | - | - | - | -628 Million |
| Other Investing Activities | -32.07 Billion | -18.86 Billion | -14.01 Billion | -24.86 Billion | -89 Billion | -11.84 Billion |
| Financing Cash Flow | 92.05 Billion | 621.2 Billion | 58.29 Billion | 48.05 Billion | 438.47 Billion | 86.7 Billion |
| Debt repayment | -102.5 Billion | -696.39 Billion | -39.55 Billion | -442.92 Billion | -521.79 Billion | -477.98 Billion |
| Dividends payments | - | -126.56 Billion | - | - | -101.44 Billion | -101.44 Billion |
| Common Stock Repurchased | - | - | - | - | -4.07 Billion | - |
| Common Stock Issuance | - | 64.49 Billion | 106.38 Billion | 41.83 Billion | 49.01 Billion | - |
| Other Financing Activities | -137.02 Billion | -11.81 Billion | -7.92 Billion | -9.83 Billion | -26.81 Billion | 666.12 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 949.52 Billion | 706.53 Billion | 855.21 Billion | 914.82 Billion | 774.94 Billion | 909.44 Billion |
| Cash at end of period | 671.98 Billion | 949.52 Billion | 706.53 Billion | 855.21 Billion | 855.21 Billion | 914.82 Billion |
| Capital Expenditure | -679.08 Billion | -582.52 Billion | -536.11 Billion | -546.01 Billion | -1680.36 Billion | -480.19 Billion |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -277.54 Billion | 242.98 Billion | -148.67 Billion | -59.61 Billion | 80.26 Billion | 5.38 Billion |
| Free Cash Flow | -337.51 Billion | -378.3 Billion | -207.25 Billion | -108.67 Billion | -360.7 Billion | -69.47 Billion |
WFHG
NATURAL
2453
BALD-B
IMUC
PSHG